The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic impact of immune checkpoint inhibitor therapy in Brazil and strategies to improve access.
 
Pedro Nazareth Aguiar
Honoraria - AstraZeneca; BMS Brazil; Novartis
Speakers' Bureau - MSD Oncology; Roche/Genentech
Travel, Accommodations, Expenses - BMS Brazil; MSD Oncology; Roche/Genentech
 
Ramon Andrade De Mello
Honoraria - AstraZeneca
Consulting or Advisory Role - Pfizer; Zodiac Pharma
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; Pierre Fabre; Roche
 
Hakaru Tadokoro
Travel, Accommodations, Expenses - MSD Oncology
 
Gilberto Lopes
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; CIPLA; Eisai; Fresenius Kabi; Janssen-Cilag; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Pfizer
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly/ImClone; Merck Sharp & Dohme; Pfizer
Expert Testimony - Sanofi